Did you suffer an eye injury after taking Elmiron?
YOU MAY BE ELIGIBLE FOR FINANCIAL COMPENSATION. COMPLETE THE FORM FOR A FREE CASE EVALUATION.
OUR PERSONAL INJURY ATTORNEYS ARE REVIEWING CLAIMS ON BEHALF OF INTERSTITIAL CYSTITIS PATIENTS WHO TOOK THE PRESCRIPTION DRUG ELMIRON AND ARE SUFFERING FROM A SEVERE EYE DISEASE CALLED MACULOPATHY
The Elmiron lawsuits are legal claims for money damages brought by consumers who took the prescription drug Elmiron to treat a chronic bladder condition called interstitial cystitis. These lawsuits allege that long-term Elmiron use causes pigmentary maculopathy which is an eye disorder affecting the macula in the central part of the retina and a major cause of permanent vision loss, distorted vision and blindness.
Recently, dozens of individuals from across the United States have taken legal action and filed Elmiron Lawsuits with the help of experienced attorneys alleging that their use of Elmiron has caused retinal injuries and vision damage, notably atypical or pigmentary maculopathy. The medication insert produced by Elmiron’s drug maker did not include any warning regarding the risk factors or dangerous side effects and vision issues or eye disease until a warning was added about pigmentary maculopathy in June of 2020. These lawsuits (often referred to as mass torts) seek compensation for Elmiron victims from the drug manufacturers and have been consolidated, through a legal process known as multidistrict litigation, into the Elmiron MDL. The Elmiron MDL is in the discovery phase of the case and is being handled in the United States District Court District of New Jersey before Judge Brian Martinotti and Judge Edward Kiel. Soon, some these Elmiron MDL cases will be selected to proceed as a bellwether trial and the outcome of these trials will have a large impact on the remaining Elmiron MDL cases.
If you or a loved one has been suffered vision loss or other eye issues after taking Elmiron (pentosan polysulfate sodium), contact the aggressive defective drug lawsuit lawyer Matthew Marin of the Marin and Barrett, Inc. law firm to find out how we can help. Elmiron lawyer Matthew Marin has been ranked as a top attorney by the SuperLawyers organization as a “Rising Star” and now a “SuperLawyer” from 2014 through 2022. Call to schedule a free, no obligation case evaluation today. Our personal injury lawyers are available 24/7 at (888) 348-2735 to take your call and stand ready to fight for the financial compensation you deserve.
The Latest Elmiron Updates
October 26, 2022: Elmiron vision loss lawsuits pending in federal court will continue to be delayed until March 2023, according to the U.S. District Judge presiding over all lawsuits. The jury trial will be closely watched for the response to certain evidence and testimony that will be repeated across hundreds of cases.
October 12, 2022: This month, despite some delays and modifications to the bellwether schedule in the Elmiron MDL, the first bellwether trial is expected to begin in January 2023. These bellwether trials will help other Elmiron plaintiffs and defendants, including Teva Pharmaceuticals and Bayer AG, help gauge how the evidence will unfold in these cases. They will also provide key insight into how juries are likely to respond to the evidence and testimony about permanent vision damage caused by Elmiron. The presentation of similar evidence and testimony in other Elmiron trials will be repeated throughout hundreds of cases pending in the federal court system.
Did you suffer an eye injury after taking Elmiron?
YOU MAY BE ELIGIBLE FOR FINANCIAL COMPENSATION. COMPLETE THE FORM FOR A FREE CASE EVALUATION.
Who is eligible to file an Elmiron vision loss lawsuit?
Our Elmiron Attorneys are evaluating claims and accepting clients who meet the following basic criteria:
1) You took Elmiron on a daily basis for 6 months or a longer extended period (long-term exposure or chronic exposure); and 2) After your use of Elmiron you experienced vision problems, visual symptoms, or other common symptoms and were diagnosed with one or more of the following conditions:
A) Pigmentary maculopathy / macular retinopathy B) Age-related macular degeneration C) Retinal dystrophy D) Other retinal conditions including retinal hemorrhage, retinal maculopathy, optic neuritis or other serve eye damage
WHAT are common ELMIRON symptoms?
Common symptoms of Elmiron-linked maculopathy include:
Blurred vision, including the center of the field of vision;
Vision loss;
Trouble reading;
Eye pain;
Less vivid, muted colors;
Straight lines appear squiggly or curved;
Dark spots in vision;
A change to the color of the retina itself;
Difficulty adjusting to dim lighting
WHAT IS ELMIRON?
Elmiron, or pentosan polysulfate sodium, is an oral prescription drug used to treat discomfort or bladder pain associated with interstitial cystitis, or IC. IC is a chronic bladder pain syndrome that causes conditions such as pain and pressure in the bladder. The drug is only available by doctor’s prescription and works by forming a layer on the bladder wall and protecting it from harmful or irritating substances in the urine. The most common side effects of Elmiron are hair loss, diarrhea and nausea. Occasionally, headache, abdominal pain, and upset stomach may occur.
DOES ELMIRON CAUSE BLINDNESS?
First reported in the American Academy of Opthalmology, new medical studies have provided evidence linking the common bladder medication Elmiron to a vision-threatening eye condition. The most recent clinical trials conducted by three ophthalmologists involved a review of patients at Kaiser Permanente in Northern California. The study revealed that one-quarter of patients with significant exposure to Elmiron suffered an adverse event with definite signs of retinal disease and eye damage, and that the medication toxicity could masquerade as other known retinal conditions, such as age-related macular degeneration or pattern dystrophy.
If you or a loved one suffered an eye or vision injury after using Elmiron, call an Elmiron Lawyer at Marin and Barrett, Inc. today at (888) 348-2735 for a free, no obligation consultation. We can help you file an Elmiron claim.
WHO MAKES ELMIRON?
Janssen Pharmaceuticals manufactures Elmiron and the U.S. Food and Drug Administration originally approved it for sale in 1996. It is currently the only oral drug approved to treat bladder pain and discomfort associated with IC (interstitial cystitis), and it is not available in generic. It is estimated that hundreds of thousands of people have used Elmiron and that most users are women. Other pharmaceutical company defendants have been included in the recent Elmiron Lawsuits including:
Janssen Pharmaceuticals, Inc. (owned by Johnson & Johnson);
Bayer Corporation;
Bayer Healthcare LLC
Bayer Healthcare Pharmaceuticals, Inc.;
Bayer US LLC;
Teva Branded Pharmaceutical Products R&D;
Teva Pharmaceuticals USA, Inc.;
IVAX LLC;
Baker Norton U.S., Inc.;
Baker Norton Pharmaceuticals, Inc.
WHAT IS THE ELMIRON LAWSUIT?
The Elmiron lawsuits claim the drug causes an eye disorder called maculopathy and other disorders of the retina that may lead to blindness. Individuals who took Elmiron and suffered retinal maculopathy, impaired vision, vision damage or other serious vision problems may be eligible to join the Elmiron lawsuit. If successful, you may be entitled to financial compensation for damages, including:
Past, present, and future medical expenses
Lost wages and lost earning potential
Pain and suffering
Compensation for loss of vision
Loss of consortium
Punitive damages, if appropriate
Unfortunately, many thought taking Elmiron was a safe and effective way to treat the chronic condition of IC. Elmiron’s medication insert did not include any warning regarding retinal damage or an increased risk of eye disease until Janssen Pharmaceuticals added a warning about pigmentary maculopathy in June 0f 2020. For this reason, the Elmiron lawsuit attorneys are seeking compensation and a fair settlement for Elmiron victims who are suffering from vision problems including blurred vision, retinal maculopathy, retinopathy, and vision impairment through the Elmiron MDL.
ELMIRON LAWYERS
The Pharmaceutical Industry is an international financial powerhouse, spending $1.2 trillion worldwide and $485 billion in the United States alone in 2018. Do not go it alone, let us fight them for you to get the compensation you rightfully deserve. We work hand in hand with some of the most experienced and respected law firms nationwide and have the resources your case needs to stand toe to toe with pharmaceutical giants. We know that the retinal damage caused by the long-term use of the prescription medication pentosan polysulfate sodium for painful bladder syndrome can lead to large medical bills. Our Elmiron lawsuit lawyers and our skilled legal team can help you take legal action by gathering your medical bills, medical records, medical history and the testimony of medical professionals to show that the pentosan polysulfate caused your eye condition and that you were not warned of the potential risks when you first started taking this dangerous drug.
At Marin and Barrett, Inc. we firmly believe that the client’s needs come above all else and have established a fully transparent fee structure to reflect that. Our Elmiron lawyers work on a strictly contingency fee basis, meaning that we do not receive anything from you unless we are able to recover money either by settlement or verdict. Regardless of what type of case you have or what is required, you will know everything up front with no surprises. We shoulder the costs of the filing and litigation on your behalf and at no risk to you until we are able to achieve a fair settlement for you.
If you took Elmiron and experienced vision loss, contact the defective drug attorneys at Marin and Barrett, Inc. today (888) 348-2735 to discuss your potential claims and schedule your free consultation, it only takes a few moments and there is no obligation to move forward with an eye damage lawsuit and join the Elmiron multidistrict litigation (MDL). Don’t delay, certain States may have laws, known as statute of limitations, that may prevent you from filing a claim and joining the litigation if wait too long to file your claim.
ATTORNEY MATTHEW MARIN
Admitted in Rhode Island, Connecticut, Massachusetts and South Carolina
ATTORNEY KENSLEY BARRETT
Admitted in Rhode Island and Massachusetts
ATTORNEY NICHOLAS PARRILLO
Admitted in Rhode Island and Massachusetts
ELMIRON DISCLAIMER: Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.